HPV vaccine after LEEP to prevent cervical changes from returning
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether getting the HPV vaccine after a LEEP (a procedure to remove abnormal cervical cells) can help prevent the abnormal cells from coming back. It's for women who have had high-grade cervical changes or very early cervical cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older and can take care of yourself (able to do daily activities).
- You have had high-grade cervical changes (precancerous cells) or very early-stage cervical cancer, and you are about to have a LEEP (a procedure to remove abnormal tissue).
- You have never received an HPV vaccine before.
- You are not having a fever on the day of vaccination, and you are not pregnant.
- You are not on medications that weaken your immune system, and you have no bleeding disorders that would make a shot risky.
- You can read and understand Italian and are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving an HPV vaccine after a cone biopsy (a surgery to remove abnormal cells from the cervix) helps prevent the HPV-related disease from coming back. It may be an option for patients who have had treatment for cervical dysplasia and have not been vaccinated against HPV before.
This trial tests whether an HPV vaccine (Gardasil 9) can help women over 45 who still have HPV after treatment for a high-grade cervical lesion. It compares vaccinated and unvaccinated patients to see if vaccination lowers the risk of the lesion coming back.
This trial tests whether getting the HPV vaccine after treatment for vulvar high-grade lesions can help prevent the lesions from coming back. It is for women who have not been vaccinated before and are about to have treatment for this condition.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This trial aims to develop a vaccine that trains your immune system to fight HPV, the virus that causes cervical cancer. By studying your blood, researchers hope to find better ways to prevent the cancer from coming back.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
Hear when a new Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.